P204: Evaluating the clinical validity of gene-disease relationships in congenital heart disease
Amy Roberts(Boston Children's Hospital), Enyonam Edoh(Broad Institute), Gillian M. Blue(Children's Hospital at Westmead), Ari Horton(Monash Children’s Hospital), Bruce D. Gelb(Child Health and Development Institute), Wendy Chung(Boston Children's Hospital), Sarah Morton(Boston Children's Hospital), Gregor Andelfinger(Centre Hospitalier Universitaire Sainte-Justine), Julie Ratliff(Broad Institute), Martina Brueckner(Yale University), Matteo Vatta(LabCorp (United States)), Kathryn Nicole Weaver(Cincinnati Children's Hospital Medical Center), Kezang Tshering(Broad Institute), Elizabeth Goldmuntz(Children's Hospital of Philadelphia), Marina Distefano(Broad Institute), Shannon N. Nees(Nemours Children's Health System)
Cited by 0
Related Papers
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
|Nature Genetics|2017|945
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies
|Science|2015|905
Thalassemia Syndromes
|Unknown|2009|475
Contribution of Global Rare Copy-Number Variants to the Risk of Sporadic Congenital Heart Disease
|The American Journal of Human Genetics|2012|338